SAN DIEGO, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that company management will present virtually at the BTIG MedTech, Digital Health, Life Science & Di
Among all the biotech pivots toward the novel coronavirus, BNGO stock represents one of the most sensible. But does that mean shares are a buy?
Bionano Genomics, Inc. (BNGO) closed at $11.80 in the latest trading session, marking a +1.29% move from the prior day.
A dazzling BNGO stock has flown under the radar in 2021, but don't expect shares of this newly-minted mid-cap to remain a secret. The post The Sequence to More Highs is Unfolding in BNGO Stock Today a
SAN DIEGO, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), announced today that its Saphyr system is being piloted by the University Health Network's (UHN) Laboratory Medicine
These high-flying stocks have been moneymakers since early November.
SAN DIEGO, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced that presentation recordings from its 5-day Next-Generation Cytogenomics Symposium, which took place from J
Bionano Genomics, Inc. (BNGO) closed at $11.85 in the latest trading session, marking a -1.41% move from the prior day.

BioNano Genomics Takes Advantage of a Spike

09:35am, Wednesday, 03'rd Feb 2021
Bionano Genomics takes advantage of a spike to sell shares at highs. Cash likely represents about 19% of the BNGO stock market capitalization as a result of two capital raises.
Mustang Bio (NASDAQ: MBIO) shares are trading higher after the company announced the FDA has lifted the clinical hold for its pivotal phase 2 MB-107 clinical trial. The company plans to enroll the fir
SAN DIEGO, Jan. 29, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced a presentation by the Director of the Clinical Cytogenomics Laboratory of Children's Hospital Los Angeles,�

Should You Buy Bionano Genomics Stock?

06:10am, Wednesday, 27'th Jan 2021
This high-flying stock is already one of the biggest winners in the new year.
Addition of Microsoft Azure as a High-Performance Computing provider reduces compute cost for genetic disease analysis by more than 50%, compute time by 30% Addition of Microsoft Azure as a High-Perfo
These popular companies have rallied between 1,000% and 2,400% since late July.
Analysts are growing more bullish on the genetic testing specialist's growth potential.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE